Clinical trialNCT00000575CompletedPhase 3Interventional

Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)

SponsorJohns Hopkins Bloomberg School of Public HealthEnrollment1,041AsthmaLung Diseases

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Anne Fuhlbrigge, MD, MS
Brigham and Women's Hospital
Principal Investigator
clinicaltrials.gov ↗
H. W. Kelly, PharmD
University of New Mexico
Principal Investigator
clinicaltrials.gov ↗
James Tonascia, PhD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗
N. F. Adkinson, MD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗
Padmaja Subbarao, MD, MSc
The Hospital for Sick Children
Principal Investigator
clinicaltrials.gov ↗
Paul Williams, MD
Asthma, Inc.
Principal Investigator
clinicaltrials.gov ↗
Robert Strunk, MD
Washington University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Robert Zeiger, MD, PhD
University of California, San Diego
Principal Investigator
clinicaltrials.gov ↗
Stanley Szefler, MD
National Jewish Health
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Budesonide →NedocromilPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 1991
Primary completion: 31 Oct 1999
Completion: 31 Mar 2012
Last update posted: 3 Apr 2014
Registered enrollment: 1,041
Registry id: NCT00000575

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.